Troubles sexuels masculins et obésité [Male sexual dysfunction and obesity].
Détails
ID Serval
serval:BIB_2DAD861D088C
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Troubles sexuels masculins et obésité [Male sexual dysfunction and obesity].
Périodique
Revue Médicale Suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
8
Numéro
365
Pages
2327-2330
Langue
français
Notes
Publication types: English Abstract ; Journal ArticlePublication Status: ppublish. PDF type: pratique
Résumé
Obesity concerns more than 200 million people in the world, with an increasing prevalence in western countries. It is closely related to multiple medical conditions, such as diabetes and hypertension. It was recently shown that testosterone deficiency syndrome and erectile dysfunction (ED) are also linked to male obesity. In this group of patients, ED may be due to defects in corpus cavernosum relaxation, endocrine modifications and nerve signal alterations. Weight loss and increased physical activities can improve erectile function in 30% of obese patients. Additional medical treatments of ED enhance erectile function in more than 80% of patients. Self image improvement associated with appropriate erectile dysfunction medical treatment allow better sexual life and potentially increased motivation for weight loss.
Mots-clé
Alprostadil/therapeutic use, Erectile Dysfunction/etiology, Erectile Dysfunction/therapy, Humans, Male, Motor Activity, Obesity/complications, Phosphodiesterase 5 Inhibitors/therapeutic use, Vasodilator Agents/therapeutic use, Weight Loss
Pubmed
Création de la notice
15/04/2013 11:05
Dernière modification de la notice
22/10/2024 6:04